Sector
HealthcareOpen
₹25.5Prev. Close
₹24.79Turnover(Lac.)
₹47.52Day's High
₹29.35Day's Low
₹25.2152 Week's High
₹35.4852 Week's Low
₹21.15Book Value
₹11.21Face Value
₹5Mkt Cap (₹ Cr.)
54.26P/E
22.54EPS
1.1Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 10.16 | 10.16 | 10.16 | 10.16 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 12.62 | 10.79 | 9.4 | 6.87 |
Net Worth | 22.78 | 20.95 | 19.56 | 17.03 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Revenue | 8.55 | 11.13 | 13.95 | 8.62 |
yoy growth (%) | -23.16 | -20.2 | 61.87 | 32.04 |
Raw materials | -0.44 | -0.65 | -0.59 | -0.72 |
As % of sales | 5.21 | 5.91 | 4.28 | 8.37 |
Employee costs | -0.91 | -1.63 | -2 | -0.96 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 2.59 | 2.66 | 3.74 | 3.28 |
Depreciation | -0.61 | -0.58 | -0.52 | -0.43 |
Tax paid | -0.58 | -0.73 | -1.05 | -0.85 |
Working capital | -3.46 | 2.67 | 0.75 | 0.45 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -23.16 | -20.2 | 61.87 | 32.04 |
Op profit growth | 12.09 | -11.54 | -14.96 | 48.54 |
EBIT growth | -9.53 | -23.48 | 6.35 | 55.99 |
Net profit growth | 4.19 | -28.54 | 10.76 | 43.42 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 12.18 | 11.73 | 12.68 | 11.96 | 16.76 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 12.18 | 11.73 | 12.68 | 11.96 | 16.76 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 0.31 | 0.31 | 0.15 | 0.14 | 0.7 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,037.85 | 96.55 | 1,01,193.48 | 251.7 | 0.23 | 1,936.6 | 536.28 |
Max Healthcare Institute Ltd MAXHEALTH | 984.55 | 133.77 | 95,711.26 | 154.14 | 0.15 | 621.39 | 79.01 |
Fortis Healthcare Ltd FORTIS | 590.8 | 337.6 | 44,602.93 | 26.83 | 0.17 | 333.4 | 120.36 |
Syngene International Ltd SYNGENE | 902.15 | 80.69 | 36,314.87 | 73.9 | 0.14 | 726.5 | 104.14 |
Global Health Ltd MEDANTA | 1,097.5 | 79.47 | 29,473.08 | 96.28 | 0 | 611.45 | 106.08 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director
Ashish Vishwas Rawandale
Non-Exec & Non-Independent Dir
Preeti Ashish Rawandale
Independent Non Exe. Director
Kiran Madhavrao Pawar
Independent Non Exe. Director
Vikramsinh Satish Khatal Patil
Non-Exec & Non-Independent Dir
SANJAY BHIKAJIRAO KHATAL
Independent Non Exe. Director
Suhas Vasantrao Thorat
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Tejnaksh Healthcare Ltd
Summary
Tejnaksh Healthcare Limited was incorporated in February 18, 2008. The Company is engaged in provision of hospital and healthcare and pharmacy services in Mumbai and other parts of Maharashtra. The Company has one subsidiary company, Tej Vedaant Healthcare Private Limited. In innovations, the Company has more than 150 research papers, 23 innovations, 13 patents applied, multiple national and international awards and to top it off, have multiple records in the Guinness Book, Limca Book, Asia & Ripleys Book. Today, the Company takes pride in manufacturing and distribution of many patented products. Being one of the leading innovative healthcare providing brands in the country, the Company continues to fathom newer avenues, break through newer achievements and reach newer heights.Initiated with a vision to strengthen healthcare in rural India, the Company started its journey from Institute of Urology, a state of the art flagship, kidney care center in Dhule in the year 2003. The only healthcare IPO from the area and the speciality, the Company has been an ardent believer of high ethical and professional standards and focused on excellence in clinical services, diagnostic facilities and research. A recognized teaching institute by the Ministry of Health and Family welfare, the Company provides quality healthcare services at 13 urology clinics, 4 urology hospitals and 2 dental super specialty clinics. The Companys achievements were the multiple records that motivates the customer
Read More
The Tejnaksh Healthcare Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹26.71 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Tejnaksh Healthcare Ltd is ₹54.26 Cr. as of 20 Sep ‘24
The PE and PB ratios of Tejnaksh Healthcare Ltd is 22.54 and 2.21 as of 20 Sep ‘24
The 52-week high/low is the highest and lowest price at which a Tejnaksh Healthcare Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Tejnaksh Healthcare Ltd is ₹21.15 and ₹35.48 as of 20 Sep ‘24
Tejnaksh Healthcare Ltd's CAGR for 5 Years at -1.93%, 3 Years at -18.17%, 1 Year at -25.35%, 6 Month at -4.47%, 3 Month at 2.10% and 1 Month at 4.86%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice